Literature DB >> 6383062

Nature of amyloid deposits in hypernephroma. Immunocytochemical studies in 2 cases associated with amyloid polyneuropathy.

M C Dalakas, S Fujihara, V Askanas, W K Engel, G G Glenner.   

Abstract

Two patients who presented with amyloid polyneuropathy were found to have an amyloid-positive hypernephroma. The amyloid extracted from the tumor of one patient was purified by gel filtration and found to immunoreact by immunodiffusion, only with antiserum against denatured lambda-type amyloid protein but not with antisera against denatured kappa amyloid, AA, or prealbumin. With the unlabeled immunoperoxidase method or immunofluorescence in combination with these specific antisera, it was shown that in both patients the amyloid deposits in the tumor, kidney, lymph node, muscle, and nerve had lambda-type amyloid antigenic fibril determinants. Some regions, amyloid-negative by congo red, immunoreacted with anti-lambda antiserum and were shown to represent amyloid fibrils electron microscopically. Several plasma cells found in the tumor and lymph node immunoreacted specifically with the anti-amyloid lambda antiserum. The findings provide the first observation that the amyloid in hypernephroma can be of immunocytic origin, even in the absence of overt signs of plasma cell dyscrasia, and suggest that amyloid polyneuropathy could be the presenting sign of hypernephroma.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6383062      PMCID: PMC1900464     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

1.  Amyloid fibril protein AA: purification and properties of the antigenically related serum component as determined by solid phase radioimmunoassay.

Authors:  J D Sipe; T F Ignaczak; P S Pollock; G G Glenner
Journal:  J Immunol       Date:  1976-04       Impact factor: 5.422

Review 2.  Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts).

Authors:  G G Glenner
Journal:  N Engl J Med       Date:  1980-06-05       Impact factor: 91.245

3.  Primary localized amyloidosis of the genitourinary tract: immunohistochemical study on eleven cases.

Authors:  S Fujihara; G G Glenner
Journal:  Lab Invest       Date:  1981-01       Impact factor: 5.662

4.  Scanning for soft-tissue amyloid.

Authors:  R W Kula; W K Engel; B R Line
Journal:  Lancet       Date:  1977-01-08       Impact factor: 79.321

5.  Identification and classification of amyloid in formalin-fixed, paraffin-embedded tissue sections by the unlabeled immunoperoxidase method.

Authors:  S Fujihara; J E Balow; J C Costa; G G Glenner
Journal:  Lab Invest       Date:  1980-10       Impact factor: 5.662

6.  Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy.

Authors:  P P Costa; A S Figueira; F R Bravo
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

7.  Amyloid fibril protein in type I familial amyloidotic polyneuropathy in Japanese.

Authors:  S Tawara; S Araki; K Toshimori; H Nakagawa; S Ohtaki
Journal:  J Lab Clin Med       Date:  1981-12

8.  Identification and characterization of different amyloid fibril proteins in tissue sections.

Authors:  G G Cornwell; G Husby; P Westermark; J B Natvig; T E Michaelsen; B Skogen
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

9.  Amyloid in hereditary amyloid polyneuropathy is related to prealbumin.

Authors:  M C Dalakas; W K Engel
Journal:  Arch Neurol       Date:  1981-07

10.  Amyloidosis with plasma cell dyscrasia. An overlooked caused of adult onset sensorimotor neuropathy.

Authors:  J L Trotter; W K Engel; F I Ignaczak
Journal:  Arch Neurol       Date:  1977-04
View more
  3 in total

1.  Characterization of renal amyloid derived from the variable region of the lambda light chain subgroup II.

Authors:  M M Picken; G Gallo; J Buxbaum; B Frangione
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

2.  Characterization of amyloid deposits in biopsies of 15 with "sporadic" (non-familial or plasma cell dyscrasia amyloid polyneuropathy.

Authors:  M C Dalakas; G Cunningham
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

Review 3.  The use of mouse models to understand and improve cognitive deficits in Down syndrome.

Authors:  Ishita Das; Roger H Reeves
Journal:  Dis Model Mech       Date:  2011-08-04       Impact factor: 5.758

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.